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Santiago1, M. Ortiz del Castillo1, M. C. Alonso-Rodrı́guez5, E. M. Sánchez Morla6, A. López-
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To determine if a novel analysis method will increase the diagnostic value of the multifocal
electroretinogram (mfERG) in diagnosing early-stagemultiple sclerosis (MS).
Methods
We studied the mfERG signals of OD (Oculus Dexter) eyes of fifteen patients diagnosed
with early-stageMS (in all cases < 12months) and without a history of optic neuritis (ON) (F:
M = 11:4), and those of six controls (F:M = 3:3). We obtained values of amplitude and
latency of N1 and P1 waves, and a method to assess normalized root-mean-square error
(FNRMSE) betweenmodel signals and mfERG recordings was used. Responses of each eye
were analysed at a global level, and by rings, quadrants and hemispheres. AUC (area under
the ROC curve) is used as discriminant factor.
Results
The standard method of analysis obtains further discrimination between controls and MS in
ring R3 (AUC = 0.82), analysing N1 waves amplitudes. In all of the retina analysis regions,
FNRMSE value shows a greater discriminating power than the standard method. The highest
AUC value (AUC = 0.91) was in the superior temporal quadrant.
Conclusion
By analysingmfERG recordings and contrasting them with those of healthy controls it is
possible to detect early-stageMS in patients without a previous history of ON.
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Introduction
The multifocal electroretinogram (mfERG) technique obtains objective and qualitative mea-
surements regarding the functioning of the retina excited with different types of visual stimuli,
and was developed for the simultaneous detection of the electrical activity from specific sectors
of the retina [1]. A major advantage of the mfERG technique is that it reveals bipolar cell func-
tionality (mainly) and photoreceptor contribution, as well as the spatial distribution of the
aforementioned sensitivity [2].
In the mfERG recordings, the retina is divided into a defined number of sectors with hexag-
onal shape (61 or 103). In the ISCEV standard stimulus array is scaled to elicit comparable
response amplitudes from each stimulus sector, resulting in larger hexagons with increasing
eccentricity [3]. Visual stimulation between black and white in each hexagon is regulated by a
pseudo-randomized sequence (m-sequence) [4]. It is possible to obtain an individualized
response in each sector through the correlation between the continuous signal registered in
the electrodes and the m-sequence.
The standard stimulus of the mfEGR provides the first-order kernel (FOK), a response to a
dark-to-light or light-to-dark stimulus. The response in the FOK comes from the receptor cells
and the “on” or “off” bipolar cells in each hexagon [1].
In past studies, the diagnostic measurements most commonly taken in mfERG recordings
were the amplitudes and latencies of N1 and P1 waves [5]. It is possible to form groups (Fig 1)
of answers from the trace arrays of the full visual field (SUM), rings (R1. . .R5), quadrants (ST:
superior temporal, IT: inferior temporal, IN: inferior nasal, SN: superior nasal) and hemiret-
inal areas: SH (superior hemifield = ST+SN), IH (inferior hemifield = IT+IN), TH (temporal
hemifield = ST+IT) and NH (nasal hemifield = IN+SN).
Multiple sclerosis (MS) is a neurodegenerative disease characterized by chronic demyelin-
ation of the central nervous system and which, as it develops, severely compromises patients’
quality of life. There is no single biomarker which is valid for diagnosis of MS; several are used
instead, including clinical diagnosis, magnetic resonance imaging (MRI), cerebrospinal fluid
data and evoked potentials. MRI can be considered the most important tool to diagnose and
monitor multiple sclerosis [6]. However, the last review of the McDonald criteria [7]
highlighted the need to perform further research into optic nerve involvement, validation in
diverse populations and incorporation of advanced imaging and neurophysiological and body
fluid markers. Evoked potentials are more closely related to clinical disability than structural
data [8], making it possible to anticipate clinical deterioration based on the high correlation
observed with the Expanded Disability Status Scale [9], even in progressive forms of MS [10].
The aim of this study is to analyse the ability of mfERGs to diagnose MS at an early stage of
the disease. Two methods of analysis were investigated; the first one based on standard mea-
sures of amplitudes and latencies of N1 and P1 waves; the second method consists of building
a signal model from subject control recordings and comparing these under assessment with
this model.
Methods
The study procedures were performed in accordance with the tenets of the Declaration of Hel-
sinki, and the study protocol was approved by the local ethics committees [Clinical Research
Ethic Committee of Aragon (CEICA, Zaragoza, Spain)]. Written informed consent to partici-
pate in the study was obtained from all subjects.
Recordings were acquired in the Ophthalmology Service of the University Hospital Miguel
Servet (Zaragoza, Spain). mfERG signals of both eyes in 15 subjects (F:M = 11:4) with early
diagnosis (inferior to 12 months) without previous history in optic neuritis and 6 healthy
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controls (F:M = 3:3) were used. The mean age (SD) was 44.47 (8.24) years for the patients and
35.75 (10.57) years for the controls. There was no significant difference between the two
groups with respect to age.
MS was diagnosed based on the 2010 revision of the McDonald Criteria [11] confirmed by
a neurologist specializing in MS. Patients with a visual acuity of less than 20/32 on the Snellen
scale or 0.2 on the ETDRS scale, intraocular pressure > 20 mmHg, and/or active MS flare (of
any neurologic deficit) in the 3 months preceding their enrolment into the study or at any of
the annual visits were excluded from the study. Active MS flare was considered a reason for
exclusion because acute axonal loss could mask neuronal damage secondary to MS progression
(i.e., chronic neurodegeneration), which was the main purpose of this study.
The participants had no concomitant ocular diseases, nor any previous history of retinal
pathology, glaucoma, amblyopia or significant refractive errors (more than 5 dioptres of spher-
ical equivalent refraction or 3 dioptres of astigmatism), or systemic conditions that could affect
the visual system.
A complete neuro-ophthalmic examination, including assessment of best-corrected visual
acuity using the Snellen and ETDRS charts, contrast sensitivity with CSV1000 test, colour
vision with Ishihara, pupillary reflexes, ocular motility; examinations of the anterior segment,
intraocular pressure (IOP) with the Goldmann applanation tonometer, and papillary mor-
phology by funduscopic exam was performed in all subjects in order to detect any ocular alter-
ation (such as primary open angle glaucoma, cataract, corneal pathology) that may affect
functional vision or mfERG results.
The first order mfERG kernel was obtained according to the ISCEV standard [5] using a
Roland Retiscan system. The stimulus configuration used was the 61 hexagon array (Fig 1)
scaled with eccentricity (the area of the hexagons increases towards periphery to compensate
for lower cone density).
A monocular recording of both eyes was carried out randomly, selecting in first place OD
(Oculus Dexter) or OS (Oculus Sinister) in each subject. To improve fixation stability, sessions
were broken into 47-s segments and 8 trials were recorded in total. The frame rate was 59.81
Hz, the amplifier gain 104 and bandwidth 10–200 Hz. The signals have been digitized with a
sampling rate of 1017 samples/sg, being 84 the number of samples in each recording (length
82.61 ms).
Fig 1. Stimulated visual field. In this figure the hexagons are not scaled with retinal eccentricity. (a) Definition of the
rings (R1, . . . R5). (b) Definition for OD of the quadrants: ST, IT, SN, IN.
https://doi.org/10.1371/journal.pone.0224500.g001
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The mfERG recordings from OD eyes were used. Individual mfERG responses for the 61
hexagons were grouped all together (whole field: SUM), into five concentric rings centred on
the fovea for analysis: R1 (0–1.75˚, 16 degrees2, 1 hexagon), R2 (6.25˚, 23 degrees2, 6 hexagons,
perifoveal ring), R3 (11.5˚, 36 degrees2, 12 hexagons), R4 (17.85˚, 51 degrees2, 18 hexagons)
and R5 (25.3˚, 69 degrees2, 24 hexagons) (Fig 1A), in four quadrants (ST, IT, IN, SN) and in
the nasal (NH), temporal (TH), superior (SH) and inferior (IH) hemifields (Fig 1B).
Recordings’ analysis
In this study, two methods of analysis of the mfERG recordings are compared: a) standard
method based on the amplitudes and latencies of N1 and P1 waves’ measuring, and b) method
of averaging of the controls database.
Standard method
Using functions we developed in Matlab, the amplitudes (AN1, AP1) and latencies of waves N1
and P1 (LN1, LP1) are calculated according to Hood et al. [5]. The location of N1 corresponds
to the minimum recording inside the temporal window of 9 to 32 ms and P1 location is the
maximum in the interval: (max{19, LN1} to 50) ms. The definition of the parameters is shown
in Fig 2.
Control recording averaging
The signals from OD eyes of 6 control subjects (x1,. . .xM = 6) have been used to obtain a model
signal of each mfERG averaging signal: sum, rings, quadrants and hemifields. The model signal
Fig 2. Waveform of first order kernel multifocal electroretinogram (mfERG) response (nV); SUM aggrupation of
a control subject. Definition of the measurements of the parameters of waves N1 and P1.
https://doi.org/10.1371/journal.pone.0224500.g002
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yM (k) is built averaging M = 6 signals in the temporal domain.





xi kð Þ k ¼ 1 . . . :84ð Þ
A model signal is obtained for each grouping under assessment: ySUMM ðkÞ; y
R1
M ðkÞ; . . . y
R5
M ðkÞ;




M ðkÞ; . . . ; y
NH
M ðkÞ. In Fig 3 the averaging signals for the following group-
ings are shown: R5 and ST.
In order to characterize a signal in a defined group, it is compared to the model signal of
that region using a standardized root-mean-square error (FNRMSE):




where yM is the averaging signal and y the one whose evaluation is required. In case the fitting
is perfect, FNRMSE = 100.
Statistical analysis
All statistical analyses were performed using the SPSS 25.0 software (SPSS Inc. Chicago, Illi-
nois, USA) and STATGRAPHICS Centurion XVII. The results were expressed as the mean
and the standard deviation. A p value below 0.05 was considered statistically significant.
The normality of the results was assessed using the Shapiro-Wilk (W) test. The differences
between groups were evaluated using the independent t-test in normal distributions or the
U-Mann-Whitney (Wilcoxon) test in non-normal distributions. The differences between meth-
ods were evaluated using the dependent t-test in normal distributions (paired-samples t-test).
Results
Standard method
In Fig 4 mfERG signals (in amplitude units: nV) of a healthy control and a patient with MS are
shown.
Fig 3. Model signals corresponding to the following regions: (a) R5 and (b) ST quadrant.
https://doi.org/10.1371/journal.pone.0224500.g003
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The mean values of amplitude and latency of N1 and P1 peaks obtained for each database
are shown in Table 1 (standard method).
The four parameters AN1, LN1, AP1 and LP1 present a Pearson correlation positive and sig-
nificant (p<0.05) among themselves, being the highest correlation r = 0.867 between AN1 and
AP1, and therefore being the behaviour in both amplitudes very similar, as it is shown in (Fig
5A and 5B). In the ring analysis, amplitudes AN1 and AP1 have a maximum value in R1 (fovea)
and progressively decrease to the exterior (parafovea, perifovea) due to the existence of a maxi-
mum concentration of cones in the fovea that decreases towards the periphery [12]. Only
amplitude N1 significantly discriminated between controls and MS patients (U Mann-Whit-
ney test) in Ring3 (p = 0.023) and IN (p = 0.036).
There is no significant difference in any analysis regions between controls and MS in the
N1 latency (U Mann-Whitney, p>0.095) and P1 amplitude (U Mann-Whitney, p>0.132)
parameters.
Fig 4. Multifocal electroretinogram (mfERG) first order kernel (nV) trace array obtained from a control subject (a)
and a multiple sclerosis (MS) patient (b).
https://doi.org/10.1371/journal.pone.0224500.g004
Table 1. Mean and standard deviation (SD) values of amplitudes and latencies in controls (C) and multiple sclerosis (MS) patients.
Region AN1(nV) LN1 (ms) AP1 (nV) LP1(ms)
C MS C MS C MS C MS
SUM 160.41(53.87) 155.44(82.84) 24.75(0.74) 23.07(3.52) 469.09(134.02) 448.30(199.04) 42.77(2.13) 42.02(3.40)
R1 308.17(79.95) 533.49(456.84) 25.89(4.60) 26.22(4.18) 986.50(196.80) 1336.15(757.21) 49.00(0.40) 44.05(7.85)
R2 207.73(59.18) 274.29(130.37) 25.40(2.60) 22.16(4.94) 612.22(139.13) 780.36(264.38) 45.56(1.72) 42.74(3.86)
R3 179.97(45.95) 266.06(96.70) 24.25(1.48) 22.62(3.83) 517.28(101.32) 660.74(242.30) 41.79(2.55) 41.56(4.31)
R4 161.17(58.22) 201.03(92.54) 24.25(1.02) 22.16(3.42) 464.08(150.25) 530.63(199.18) 42.77(2.13) 43.13(2.65)
R5 158.06(63.45) 176.27(90.63) 23.60(2.06) 21.76(5.90) 458.38(131.61) 478.24(167.64) 42.45(2.28) 41.95(4.10)
ST 195.55(41.52) 228.98(200.02) 24.09(1.36) 22.22(3.73) 583.38(83.32) 613.89(341.15) 43.10(1.80) 42.41(3.40)
IT 148.12(67.56) 186.46(95.40) 24.42(1.80) 21.44(5.90) 425.81(161.75) 493.95(177.68) 41.63(3.15) 39.72(5.17)
IN 137.41(66.43) 258.50(136.53) 23.93(2.12) 23.21(4.28) 411.36(174.57) 596.14(249.49) 40.97(3.66) 42.02(3.25)
SN 188.45(70.19) 227.41(88.25) 23.76(1.15) 22.94(4.80) 524.81(137.57) 594.56(161.51) 42.94(1.72) 42.22(5.56)
SH 186.06(56.03) 186.20(73.51) 24.42(0.74) 22.03(3.95) 542.37(115.97) 531.38(181.87) 42.94(1.61) 40.31(6.74)
IH 139.34(62.06) 176.39(73.96) 24.09(1.73) 23.21(3.71) 409.97(160.61) 467.64(171.50) 41.46(3.20) 42.02(3.61)
TH 169.01(45.16) 175.22(71.61) 24.25(1.48) 21.76(4.89) 494.17(109.44) 503.73(180.31) 42.77(2.13) 40.90(4.53)
NH 159.17(64.36) 199.50(79.04) 23.76(1.15) 23.01(3.77) 454.31(152.16) 510.18(178.36) 42.94(1.93) 41.49(5.40)
AN1: amplitude of wave N1; LN1: latency of wave N1; AP1: amplitude of wave P1; LP1: latency of wave P1; C: controls; MS: patients; SUM: whole field; R1,. . .R5: Ring
1,. . .Ring 5; ST: superior temporal quadrant; IT: inferior temporal quadrant; IN: inferior nasal quadrant; SN: superior nasal quadrant; SH: superior hemifield; IH:
inferior hemifield; TH: temporal hemifield; NH: nasal hemifield.
https://doi.org/10.1371/journal.pone.0224500.t001
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The latency of wave P1 only presents significant differences between controls and MS in
Ring1 (U Mann-Whitney, p = 0.018) (Fig 5C and 5D). LP1 presents a value significantly supe-
rior in the fovea, progressively decreasing to the parafovea and the perifovea in both MS and
controls.
Table 2 shows FNRMSE values in controls and MS patients. To obtain FNRMSE values in the 6
control eyes, the averaging signal has been built by means of cross-validation in 6 folds (leave-
one-out cross-validation: M = 5, the analysed signal is not used to construct the model). To
obtain the FNRMSE values of MS patients, the averaging signal has been implemented with all
the eyes of controls (M = 6).
FNRMSE values in controls exceed significantly (t-student independent samples test,
p<0.0001) (Fig 5E) the values obtained from MS signals, since the model signal is built from
control signals. FNRMSE presents a significant negative correlation with both amplitudes and
latency of P1 wave. FNRMSE regional behaviour can be seen in Fig 5E.
The capacity of discrimination between controls and MS for the standard analysis method
and the averaging method is shown in Table 3.
In the study of amplitudes and latencies (standard method) and considering the average
value in every possible region as criteria for comparability, the most discriminant parameter is
the amplitude of N1 wave (meanðAUCAN1Þ ¼ 0:62). The visual field region analysed with
greater AUC value in mean value is R2 (mean(AUCR2) = 0.71). As best option using the stan-
dard method, the maximum capacity of discrimination could be obtained just analysing the
N1 amplitude in R3: (AUCAN1R3 ¼ 0:82).
FNRMSE value synthesizes in just one parameter the comparison of the shapes of the wave,
against the 4 parameters used in the traditional method. In the study of the different regions,
in all cases the AUC value with FNRMSE parameter exceeds or evens (IN region) the mean value
in the standard method.
Fig 5. Principal results of the multifocal electroretinogram (mfERG) analysis.
https://doi.org/10.1371/journal.pone.0224500.g005
Table 2. Mean and standard deviation (SD) of normalized root-mean-square error function (FNRMSE) in controls
and multiple sclerosis (MS) patients.
Region Controls MS p value
SUM 58.0(16.9) 34.2(28.4) 0.086
R1 49.1(9.5) -32.7(122.3) 0.014
R2 56.4(13.1) 3.4(70.6) 0.010
R3 53.7(12.5) 3.4(69.4) 0.018
R4 46.1(21.1) 2.1(59.5) 0.035
R5 44.5(14.9) 2.5(50.7) 0.036
IN 38.1(27.0) 5.8(56.5) 0.127
SN 53.6(16.9) -8.6(91.9) 0.025
ST 60.6(12.2) 18.2(54.8) 0.013
IT 33.2(19.3) -17.8(75.9) 0.097
SH 62.9(13.6) 27.5(35.3) 0.036
IH 39.6(22.8) 20.5(36.5) 0.087
TH 56.9(13.5) 25.4(31.5) 0.126
NH 52.6(21.5) 18.0(51.0) 0.045
SUM: whole field; R1,. . .R5: Ring 1,. . .Ring 5; ST: superior temporal quadrant; IT: inferior temporal quadrant; IN:
inferior nasal quadrant; SN: superior nasal quadrant; SH: superior hemifield; IH: inferior hemifield; TH: temporal
hemifield; NH: nasal hemifield.
https://doi.org/10.1371/journal.pone.0224500.t002
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The mean value of AUC values using FNRMSE parameter is 0.76 (meanðAUCFNRMSEÞ ¼ 0:76)
in comparison with the average value obtained with the standard method: mean(AUCSTANDARD)
= 0.60). The greatest discriminant value is obtained in the ST quadrant analysis ðAUCFNRMSEST ¼
0:91Þ and the SH hemisphere ðAUCFNRMSESH ¼ 0:84Þ.
Discussion
In this study, the differences in mfERG signals in control subjects and MS patients have been
analysed using the standard method of measure for amplitudes and latencies of N1 and P1
waves, as well as a method based on the comparison of recordings with a reference template
obtained from control signals.
There are few previous studies which analyse mfERG signals in patients with MS, and due
to its heterogeneity (different types of patients, acquisition systems and analysis of recordings,
reduced databases, etc.) the results are contradictory. On the other hand, in our study the most
innovative and ambitious aspect is the use of patients with an early diagnosis (less than 6
months from their first symptom) and with no symptoms of visual acuity loss nor optic neuri-
tis, since our aim was to assess the effects of the disease themselves and the existence of axonal
degeneration and the affectation of the nerve impulse conduction in the visual canal since the
beginning of the pathology. For this reason, we avoided patients with previous optic neuritis,
in order to avoid biases including eyes in which inflammation of the optic nerve or visual atro-
phy can affect the nervous conduction of the visual channel significantly.
Gundogan et al [13] reported that there was no significant difference in P1 and N1 ampli-
tude and implicit times in different rings, between patients with MS (without a history of optic
neuritis) and control subjects. Nevertheless, in Saidha et al [14] it is valued that all waves of the
Table 3. Measurements of area under ROC (receiver operating characteristic curve) (AUC) using standard method and normalized root-mean-square error func-
tion (FNRMSE) to discriminate between multiple sclerosis patients and controls.
Region AUC values
Parameters Methods
AN1 LN1 AP1 LP1 Mean by region
(standard method)
FNMRSE
SUM 0.50 0.65 0.57 0.53 0.56 0.76
R1 0.54 0.51 0.64 0.83 0.63 0.69
R2 0.67 0.68 0.74 0.73 0.71 0.78
R3 0.82 0.64 0.71 0.53 0.68 0.80
R4 0.64 0.72 0.61 0.56 0.63 0.76
R5 0.54 0.54 0.56 0.53 0.54 0.81
IN 0.80 0.54 0.71 0.61 0.67 0.67
SN 0.66 0.55 0.59 0.56 0.59 0.80
ST 0.52 0.58 0.54 0.52 0.54 0.91
IT 0.61 0.61 0.60 0.60 0.61 0.74
SH 0.53 0.70 0.51 0.54 0.57 0.84
IH 0.64 0.53 0.58 0.59 0.58 0.67
TH 0.69 0.54 0.59 0.53 0.59 0.81
NH 0.56 0.62 0.51 0.59 0.57 0.71
Mean by parameter 0.62 0.60 0.60 0.59 0.60 0.76
AN1: amplitude of wave N1; LN1: latency of wave N1; AP1: amplitude of wave P1; LP1: latency of wave P1; SUM: whole field; R1,. . .R5: Ring 1,. . .Ring 5; ST: superior
temporal quadrant; IT: inferior temporal quadrant; IN: inferior nasal quadrant; SN: superior nasal quadrant; SH: superior hemifield; IH: inferior hemifield; TH:
temporal hemifield; NH: nasal hemifield.
https://doi.org/10.1371/journal.pone.0224500.t003
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first-kernel order showed normal latencies in all MS patients but a reduction of P1 amplitude
is detected in 5 of 7 patients with predominant macular thinning. In Neroev et al [15] the use
of the wave P1 latency in the parafovea as a marker of MS progression is suggested. Recently
Hanson et al [16] observed that in a typical MS cohort, latency of wave P1 increases (in ring 2)
whereas there is no difference observed in amplitudes.
In the present study, it can be observed that on average the most discriminant parameter to
detect signals from MS patients is the amplitude of the N1 wave (meanðAUCAN1Þ ¼ 0:62). The
most valuable region of the visual field for discriminating between controls and MS patients is
ring R2 (mean(AUCR2) = 0.71). As a general idea, in the standard method the capacity of dis-
crimination is low (AUCs always below 0.71).
In the second part of our study, the use of an averaging method is proposed to generate a
signal template of controls which can be used to verify the degree of fitting, evaluated by
means of mean squared error. FNRMSE in controls is superior to MS patients (p<0.0001). With
this new method, we observe that AUC between healthy controls and MS patients increases in
most regions of the retina analysis (except in region IN). An advantage of the FNRMSE parame-
ter is that this one models the mfERG signal form through a characteristic that defines the
global wave form of the acquired signals, in comparison with the control subject signals.
With the obtained results of the averaging parameter FNRMSE, we have observed that the
greatest discriminating power is produced in the ST region (AUCFNRMSEST ¼ 0:91), improving
results obtained in the analysis of amplitudes and latencies. Previous studies carried out with
OCT also point to temporal sectors as the ones which present an early affectation at early
stages of the disease [17].
Our population was composed of patients with early-stage MS, so markedly delayed trans-
mission of nerve stimulation was not yet apparent. We also detected more subclinical alter-
ations in mfERG amplitudes than in mfERG latencies. Probably, when MS progresses in our
population or MS outbreaks causes myelin loss, we will detect more alterations in mfERG
latencies.
In our patients, we found affectation in the superior temporal quadrant. This concurs with
the findings of previous authors who demonstrated early damage in the temporal RNFL quad-
rant using OCT [18]. This temporal quadrant corresponds topographically to the papillomacu-
lar bundle and is formed by the superior temporal and inferior temporal sectors. Early
neurodegeneration of the RNFL usually begins in the thickest superior temporal sector. This
occurs not only in MS [19] but also in other neurodegenerative processes such as glaucoma
[20,21], Parkinson’s disease [22] and Alzheimer’s disease [23].
In conclusion, the correct analysis of mfERG recordings can be an effective biomarker for
diagnosis of MS in subjects at early diagnosis and without previous history of optic neuritis,
which helps to accelerate the diagnosis and to apply the treatment from the early stages of the
pathology, avoiding the reduction of patients’ quality of life and the appearance of new flare-
ups.
The main limitation of our study is the small size of our database. In spite of this, we found
significant differences between control subjects and patients, suggesting that the diagnostic
capacity of the method may increase with sample size. Another limitation is that follow-up of
these patients and controls was not carried out. To avoid bias derived from differences
between databases, these should be extended to include subjects from other centres and signals
recorded using other commercially available equipment. In addition, this study must be
extended to other types of MS because so far just the Relapsing Remitting type has been
studied.
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